QIAGEN enters into agreement to acquire STAT-Dx Blog Post

Qiagen, a Netherlands-based holding company has entered into an agreement to acquire Stat-Dx –a privately-held company with headquarters at the Barcelona Science Park– for $191 million. The catalan biotec, founded in 2010 by Jordi Carrera and Rafael Bru, is focused on the development, manufacturing and commercialization of “Closer to Care” diagnostic solutions.

 

IRB Barcelona receives a bequest of 1.5 M € Blog Post

The Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park, has received a bequest of 1,552,655 €, which, to honour the wishes of the donors, will support research into cancer and metastasis. This is the first legacy donation that the centre has received, made by a private couple from Barcelona. In addition to this bequest, in recent years other people have expressed their wish to include IRB Barcelona in their wills.

 

The FBG awards €100,000 to four UB projects for the valorisation of research Blog Post

On 18 January, the FBG, located at PCB, presented the grants of the Valorisation Fund (FVal) of the Fund for the Promotion of Innovation (F2i). Within this funding programme, € 25,000 were awarded to each selected project, which will be used to valorize projects of the University of Barcelona with a high potential for transfer and impact on our society. 

 

EIT Health Wild Card: €4 million in search of innovative health ideas Blog Post

Under the new Wild Card programme, EIT Health consortium –the largest European body for innovation in healthy living and active ageing– has announced €4 million in funding for disruptive initiatives that help transform European healthcare and mitigate the social and economic impact of the progressive ageing of the population. The Universitat de Barcelona (UB), a core partner and promoter of EIT Health Spain, is one of the 14 European institutions that will offer advisory and incubation services to the two winning teams to turn their ideas into a business plan through of the Barcelona Entrepreneurship Institute (BIE), the Bosch i Gimpera Foundation (FBG) and the Barcelona Science Park (PCB). On Monday, January 29, an informative session will take place at the PCB.

 

SOLVE-RD: Major European grant for research into rare diseases Blog Post

The CNAG-CRG at PCB participates in a large consortium led by the University of Tübingen, the Radboud University Medical Center Nijmegen and the University of Leicester that has acquired a € 15 million grant for the SOLVE-RD research program he researchers will work directly with four European Reference Networks (ERNs) to share and enhance the knowledge and resources used for treating rare diseases.

 

Chemotargets signs a research collaboration agreement with FDA/CDER Blog Post

The Food and Drug Administration’s Center for Drug Evaluation and Research (FDA-CDER) and Chemotargets –a spin off from the IMIM Hospital del Mar Medical Research Institut and located at the Barcelona Science Park– will work together under a 5-year Research Collaboration Agreement (RCA). The collaboration aims to enhance CDER’s safety assessments of human pharmaceuticals, supporting the FDA’s mission of protecting public health.

 

Esteve picks up Company of the Year Award Blog Post

Esteve has won the Company of the Year Award 2017 which is sponsored by Grupo Zeta and Banc Sabadell and recognises contributions to creating wellbeing and progress. The pharmaceutical chemical group, which has its Drug Discovery and Preclinical Development Units at the Barcelona Science Park, is a leader in the international pharmaceutical industry due to its continuous innovation in the traditional R&D model and unswerving commitment to promoting excellence in research ecosystems. Albert Esteve, the company’s Chairman, is to collect the award today at Casa Llotja de Mar in Barcelona at a ceremony attended by a wide range of political, social and industry figures.

 

Bioinformatics company Mind the Byte acquires Intelligent Pharma Blog Post

Mind the Byte a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industry. Both bioinformatics companyies are headquartered in the Barcelona Science Park (Parc Científic de Barcelona, PCB) which will help the integration process under which Mind the Byte expects to reach €2 million in turnover by 2019.